Back
Rapid7, Inc. 10K Form
Buy
58
RPD
Rapid7, Inc.
Last Price:
$16.13
Seasonality Move:
10.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2023-08-09 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2023-05-10 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-11-03 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-08-04 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-05-05 | 10Q | RPD/Rapid7, Inc. Quarterly |
Receive RPD News And Ratings
See the #1 stock for the next 7 days that we like better than RPD
RPD Financial Statistics
Sales & Book Value
| Annual Sales: | $844M |
|---|---|
| Cash Flow: | $30.5M |
| Price / Cash Flow: | 6.68 |
| Annual Sales: | $1.95 |
| Price / Book: | 8.27 |
Profitability
| EPS (TTM): | 0.34620 |
|---|---|
| Net Income (TTM): | $22.4M |
| Gross Margin: | $581.2M |
| Return on Equity: | 39.79% |
| Return on Assets: | 1.37% |
Rapid7, Inc. Earnings Forecast
Key Rapid7, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for RPD is 68.86%.
-
The Selling, General & Administrative Expenses for RPD have been equal to 45.59% of Gross Profit Margin.
-
The Research & Development expenses have been 20.12% of Revenue.
-
The Interest Expense is 42.95% of Operating Income.
-
The Net Earning history of RPD is 3.02% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 5 years.
Rapid7, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | RPD |
| CUSIP: | 753422 |
| Website: | rapid7.com |
Debt
| Debt-to-Equity Ratio: | 7.63 |
|---|---|
| Current Ratio: | 1.1 |
| Quick Ratio: | 1.04 |
Price-to-Earnings
| Trailing P/E Ratio: | 39.75 |
|---|---|
| Forward P/E Ratio: | 8.04 |
RPD Technical Analysis vs Fundamental Analysis
Buy
58
Rapid7, Inc. (RPD)
is a Buy
Is Rapid7, Inc. a Buy or a Sell?
-
Rapid7, Inc. stock is rated a BuyThe current Rapid7, Inc. [RPD] share price is $16.06. The Score for RPD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.